Literature DB >> 8612677

The 3' untranslated region of prohibitin and cellular immortalization.

E R Jupe1, X T Liu, J L Kiehlbauch, J K McClung, R T Dell'Orco.   

Abstract

We have been studying the role of the evolutionarily conserved prohibitin gene in cellular immortalization and tumor suppression. Immortalized human cells are classified into four complementation groups (A, B, C, and D) based on the ability of fusion hybrids to become senescent. The present study expands our preliminary evidence showing that the antiproliferative activity of prohibitin is only effective in immortalized Group B cells and normal cells. Data presented here show that the expression of a prohibitin mRNA with a long 3' untranslated region (3'UTR) and prohibitin protein is elevated in immortalized cells from all complementation groups. However, all immortalized cells classified in complementation Group B, and no cell lines in any of the other groups, are sensitive to the antiproliferative activity of wild-type prohibitin transcripts. All Group B cells are also homozygous for one of two human prohibitin alleles that are distinguishable by two distinct intron polymorphism restriction sites. Interestingly, sequence analysis of the prohibitin gene from representatives of each of the complementation groups showed that the 3'UTR from Groups A, C, and D matched wild type; however, the sequence from all four Group B cell lines differed from wild type. Functional inhibition assays on truncated wild-type mRNA transcripts as well as 3'UTR specific wild-type and mutated transcripts show that the antiproliferative activity of prohibitin resides, at least in part, in the 3'UTR. These data suggest that the prohibitin 3'UTR may function as a trans-acting regulatory RNA (riboregulator) whose tumor suppressor activity has been inactivated by mutation in Group B cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612677     DOI: 10.1006/excr.1996.0120

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

Review 1.  General principals of miRNA biogenesis and regulation in the brain.

Authors:  Dónal O'Carroll; Anne Schaefer
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

3.  Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells.

Authors:  Sharmila Manjeshwar; Megan R Lerner; Xiao-Ping Zang; Dannielle E Branam; J Thomas Pento; Mary M Lane; Stan A Lightfoot; Daniel J Brackett; Eldon R Jupe
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

4.  Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.

Authors:  Paul B Romesser; David H Perlman; Douglas V Faller; Catherine E Costello; Mark E McComb; Gerald V Denis
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 5.  Noncoding RNA in development.

Authors:  Paulo P Amaral; John S Mattick
Journal:  Mamm Genome       Date:  2008-10-07       Impact factor: 2.957

6.  Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1.

Authors:  Wei Guo; Hong Xu; Jing Chen; Yong Yang; Jia Wei Jin; Rui Fu; Hai Mei Liu; Xi Liang Zha; Zhi Gang Zhang; Wen Yan Huang
Journal:  Mol Cell Biochem       Date:  2006-10-17       Impact factor: 3.396

Review 7.  Prohibitin 1 in liver injury and cancer.

Authors:  Lucía Barbier-Torres; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-20

8.  Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes.

Authors:  Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 9.  ceRNA cross-talk in cancer: when ce-bling rivalries go awry.

Authors:  Florian A Karreth; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2013-09-26       Impact factor: 39.397

10.  A proteomic comparison of immature and mature mouse gonadotrophs reveals novel differentially expressed nuclear proteins that regulate gonadotropin gene transcription and RNA splicing.

Authors:  Jiajun Feng; Mark A Lawson; Philippa Melamed
Journal:  Biol Reprod       Date:  2008-05-14       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.